As a critical m6A RNA methylation regulator, HNRNPC has been revealed to serve as potential biomarkers in various human cancers. The specific expression and significance of HNRNPC in colorectal cancer remain unknown.
OBJECTIVE:
This study aimed to confirm HNRNPC expression level and evaluate its function in colorectal cancer progression.
METHODS:
101 paired tissue samples were collected from colorectal cancer patients. HNRNPC levels in colorectal cancer were detected using PCR. CCK8 and transwell assays were conducted to estimate the effect of HNRNPC on cell growth and metastasis with the regulation of HNRNPC by cell transfection.
RESULTS:
Upregulated HNRNPC was observed in colorectal cancer compared with normal tissues and cells. The higher HNRNPC levels in tumor tissues were associated with the advanced TNM stage and positive lymph node metastasis. Meanwhile, HNRNPC upregulation could indicate adverse outcomes of colorectal cancer patients. In vitro, the knockdown of HNRNPC significantly suppressed the proliferation, migration, and invasion of colorectal cancer cells.
CONCLUSIONS:
Upregulated HNRNPC served as a biomarker for the prognosis and development of colorectal cancer, which provides a novel therapeutic target for colorectal cancer.
EngCJacomeAAAgarwalRHayatMHByndlossMXHolowatyjAN, et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol.2022; 23(3): e116-e28.
2.
BaidounFElshiwyKElkeraieYMerjanehZKhoudariGSarminiMT, et al. Colorectal cancer epidemiology: Recent trends and impact on outcomes. Curr Drug Targets.2021; 22(9): 998-1009.
3.
YuISKopetzS. The emergence of targetable pathways in colorectal cancer. Clin Adv Hematol Oncol.2021; 19(12): 774-83.
4.
ZhouZHuangHLiangY. Cancer classification and biomarker selection via a penalized logsum network-based logistic regression model. Technol Health Care.2021; 29(S1): 287-95.
5.
KanwalRGuptaKGuptaS. Cancer epigenetics: An introduction. Methods in Molecular Biology (Clifton, NJ).2015; 1238: 3-25.
6.
ZhangLLuQChangC. Epigenetics in health and disease. Advances in Experimental Medicine and Biology.2020; 1253: 3-55.
7.
LiMWangXYangLJiangYXieYLiK. Acupuncture improves learning and memory ability of posttraumatic stress disorder model rats through epigenetic regulation of microglial phosphatidylinositol 3-kinase pathway. Technol Health Care.2023; 31(S1): 409-21.
8.
ZhaoLYSongJLiuYSongCXYiC. Mapping the epigenetic modifications of DNA and RNA. Protein Cell.2020; 11(11): 792-808.
9.
ZhangYSunZJiaJDuTZhangNTangY, et al. Overview of histone modification. Advances in Experimental Medicine and Biology.2021; 1283: 1-16.
10.
ReyesAAMarcumRDHeY. Structure and function of chromatin remodelers. J Mol Biol.2021; 433(14): 166929.
11.
HeLLiHWuAPengYShuGYinG. Functions of N6-methyladenosine and its role in cancer. Mol Cancer.2019; 18(1): 176.
DaiDWangHZhuLJinHWangX. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death & Disease.2018; 9(2): 124.
14.
WangTKongSTaoMJuS. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer.2020; 19(1): 88.
15.
HuangGZWuQQZhengZNShaoTRChenYCZengWS, et al. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT. Aging.2020; 12(12): 11667-84.
16.
LvWTanYXiongMZhaoCWangYWuM, et al. Analysis and validation of m6A regulatory network: A novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression. Journal of Translational Medicine.2021; 19(1): 527.
17.
WangLCChenSHShenXLLiDCLiuHYJiYL, et al. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Frontiers in Oncology.2020; 10: 536875.
18.
WuYZhaoWLiuYTanXLiXZouQ, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. The EMBO Journal.2018; 37(23).
19.
ZhangYChenWPanTWangHZhangYLiC. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs. Biochem Biophys Res Commun.2019; 511(3): 566-72.
20.
LiuTLiCJinLLiCWangL. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma. Med Sci Monit.2019; 25: 9435-45.
21.
LiZSLiQ. The latest 2010 WHO classification of tumors of digestive system. Zhonghua Bing Li Xue Za Zhi.2011; 40(5): 351-4.
22.
CaoSLiHLiL. LncRNA SNHG17 Contributes to the Progression of Cervical Cancer by Targeting microRNA-375-3p. Cancer Manag Res.2021; 13: 4969-78.
23.
ZhaoYZhangWYangYDaiEBaiY. Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma. Bioengineered.2021; 12(1): 4747-56.
24.
TianXZhengJLuoYWeiCMaJWangD, et al. Identification of abnormally methylated differentially expressed genes in chronic periodontitis by integrated bioinformatics analysis. Technol Health Care.2023; 31(3): 809-19.
25.
CaoDXueJHuangGAnJAnW. The role of splicing factor PRPF8 in breast cancer. Technol Health Care.2022; 30(S1): 293-301.
26.
LiuTWeiQJinJLuoQLiuYYangY, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res.2020; 48(7): 3816-31.
27.
ZhangCHuangSZhuangHRuanSZhouZHuangK, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene.2020; 39(23): 4507-18.
28.
TooleyJGCatlinJPTooleyCES. METTLing in Stem Cell and Cancer Biology. Stem Cell Rev Rep. 2022.
29.
ZhouHYinKZhangYTianJWangS. The RNA m6A writer METTL14 in cancers: Roles, structures, and applications. Biochim Biophys Acta Rev Cancer.2021; 1876(2): 188609.
30.
ZengCHuangWLiYWengH. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol.2020; 13(1): 117.
31.
ZhangYLiuXLiuLLiJHuQSunR. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma. Med Sci Monit.2020; 26: e919644.
32.
TangRZhangYLiangCXuJMengQHuaJ, et al. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma. PeerJ.2020; 8: e9602.
33.
HuangHHanYZhangCWuJFengJQuL, et al. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer. Tumour Biol.2016; 37(3): 3527-34.
34.
HuangXTLiJHZhuXXHuangCSGaoZXXuQC, et al. HNRNPC impedes m(6)A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma. Cancer Lett.2021; 518: 196-206.
35.
WangSXuGChaoFZhangCHanDChenG. HNRNPC promotes proliferation, metastasis and predicts prognosis in prostate cancer. Cancer Manag Res.2021; 13: 7263-76.
36.
DuALiSZhouYDisomaCLiaoYZhangY, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer.2022; 21(1): 109.
37.
YangDChangSLiFMaMYangJLvX, et al. m(6) A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1. IUBMB Life.2021; 73(11): 1325-33.
